Podiatry Board of Australia
Podiatry Board of Australia
 

Endorsement for scheduled medicines

Endorsement of registration identifies practitioners with additional qualifications and specific expertise. The endorsement available for podiatry is scheduled medicines.

The Board has approval from the Australian Health Workforce Ministerial Council (Ministerial Council) to endorse the registration of a podiatrist or podiatric surgeon as being qualified to administer, obtain, possess, prescribe, sell, supply or use Schedule 2, 3, 4 or 8 medicines for the treatment of podiatric conditions from the list of scheduled medicines approved by the Board (the National podiatry scheduled medicines list).

Document name  PDF  Document date 
Endorsement for scheduled medicines registration standard  PDF 
(250 KB) 
01 July 2010 
Podiatry guidelines for endorsement for scheduled medicines  PDF 
(811 KB) 
01 July 2010 
Endorsement for scheduled medicines: Information package  PDF 
(779 KB) 
30 September 2011 
Podiatry policy on extension of time to complete Pathway 2  PDF 
(84.3 KB) 
21 December 2011 
Podiatry policy on log sheets for endorsement of scheduled medicines  PDF 
(74.9 KB) 
28 December 2011 
Sample log sheet for endorsement of scheduled medicine  PDF 
(129 KB) 
19 March 2012 
FAQ on endorsement for scheduled medicines  PDF 
(309 KB) 
01 July 2010 
Prescribing information for podiatrists endorsed for scheduled medicines  PDF 
(332 KB) 
01 July 2010 

For the purpose of the Board’s Endorsement for scheduled medicines registration standard the Board will accept the following as an approved program of study in podiatric therapeutics:

  • A program of study in podiatric therapeutics that has been accredited for this purpose by the Australia and New Zealand Podiatry Accreditation Council [ANZPAC] and approved by the Board
  • A program of study that transitioned on the commencement day of the National Law as an ‘approved program of study in podiatric therapeutics’ (section 283 of the National Law)
  • A program of study in podiatric therapeutics that, in the Board’s opinion, is substantially equivalent to, or based on similar competencies to, an approved program of study (section 94 (1) (a) (ii) of the National Law).

An online search is available for all approved programs of study..

A list of programs of study that the Board considers to be substantially equivalent to, or based on similar competencies to, an approved program of study in podiatric therapeutics for endorsement for scheduled medicines is located under Accreditation.

The Board has set a currency period of seven years for the purpose of an endorsement for scheduled medicines.

This is to ensure that a practitioner who has completed an approved program of study has maintained their knowledge in podiatric therapeutics since completing the program of study. This applies to both Pathway 1 and Pathway 2 applicants.

From 1 January 2013, practitioners whose qualification in podiatric therapeutics is more than seven years old will be required to complete another approved program of study in podiatric therapeutics before applying for an endorsement for scheduled medicines via Pathway 1 or commencing Pathway 2 towards an endorsement for scheduled medicines.

Background

The requirements for endorsement are set out in the Board’s Endorsement for scheduled medicines registration standard and explained in the Guidelines and Information Package. A podiatrist or podiatric surgeon who wishes to apply to the Board to have their registration endorsed for scheduled medicines may follow one of two pathways (Pathway 1 or Pathway 2) to meet the Board’s requirements for an application for endorsement for scheduled medicines.

Process for the assessment by ANZPAC of qualifications in podiatric therapeutics that are not on the Board’s list of approved qualifications for ESM

  •  Practitioners wishing to work towards/apply to have their registration endorsed for scheduled medicines should check under Accreditation for the current list of approved qualifications in podiatric therapeutics for ESM. 
  • If a practitioner does not have an approved qualification in podiatric therapeutics, the practitioner has the option to either:
    • Undertake an approved program of study in podiatric therapeutics; or
    • Have their qualification in podiatric therapeutics assessed by ANZPAC to ascertain if it is substantially equivalent, or based on similar competencies to an approved qualification in podiatric therapeutics. 
  •  Practitioners should liaise directly with ANZPAC regarding the assessment of their qualification in podiatric therapeutics. ANZPAC’s contact details are available on the ANZPAC website
  • If a practitioner decides to have their qualification in podiatric therapeutics assessed by ANZPAC, this should be done prior to undertaking the other requirements for ESM (ie. web based case studies and 40 sessions of supervised practice [40 log sheets]).

If the practitioner’s qualifications are assessed by ANZPAC as not being equivalent to an approved qualification in podiatric therapeutics, the practitioner has the opportunity to undertake an approved program of study in podiatric therapeutics before they commence the other requirements for ESM.

The Board recommends the following sequence of learning for podiatrists or podiatric surgeons who are following Pathway 2 towards applying to the Board to have their registration endorsed for scheduled medicines:

  1. Complete an approved program of study in podiatric therapeutics;
  2. Complete web based case studies;
  3. Complete log sheets.

One of the requirements for podiatrists or podiatric surgeons who are following Pathway 2 towards applying to the Board to have their registration endorsed for scheduled medicines is the successful completion of 15 web-based case studies approved by the Board.

The Board has approved the following web-based case studies for the purpose of endorsement for scheduled medicines:

  • Web-based case studies offered by LaTrobe University
  • Web-based case studies offered by the Queensland University of Technology (QUT) as part of the Graduate Certificate in Podiatric Therapeutics

The currency period for web-based case studies is three years for the purpose of an application for endorsement for scheduled medicines.

The Podiatry Board of Australia provides the following templates for Prescription Pads for the consideration of use by those generally registered podiatrists who also have an endorsement for scheduled medicines; and for those generally registered podiatrists who have an endorsement for scheduled medicines and are also registered as podiatric surgeons.

The Podiatry Board of Australia strongly recommends the inclusion of a carbon copy facility and numbering system for each page on any prescription pad.

Document title  PDF  Document date 
Prescription pad for podiatric surgeon with endorsement for scheduled medicines  PDF (256 KB)  01 July 2010 
Prescription pad for podiatrist with endorsement for scheduled medicines  PDF (254 KB)  01 July 2010 

Copies of documents provided in support of an application, or other purpose required by the National Law, must be certified as true copies of the original documents.

See Certifying Documents on the AHPRA web site. 

The National Law provides that the Podiatry Board of Australia (Board) may endorse a practitioner’s registration as being qualified to administer, obtain, possess, prescribe, sell, supply or use Schedule 2, 3, 4 or 8 medicines to patients for the treatment of podiatric conditions. An endorsement for scheduled medicines may be subject to a condition if the Board considers it necessary or desirable in the circumstances or if the condition was in effect prior to the commencement of the National Law.

The following scheduled medicines lists relate to podiatrists whose registration is endorsed for scheduled medicines subject to a condition. For example, the podiatrist's endorsement may state that it is subject to condition and the condition is that they are qualified to administer, obtain, possess, prescribe, sell, supply or use the scheduled medicines listed in one of the following lists ie. 'Scheduled Medicines List B'.

Document name  PDF  Document date 
Scheduled Medicines List A  PDF 
(34.4 KB) 
18 August 2011 
Scheduled Medicines List B  PDF 
(34.2 KB) 
18 August 2011 
Scheduled Medicines List C  PDF 
(8.91 KB) 
18 August 2011 
Scheduled Medicines List D  PDF 
(141 KB) 
18 August 2011 
Scheduled Medicines List E  PDF 
(130 KB) 
18 August 2011 

 
 
 
 
Page reviewed 15/01/2014